Day: November 17, 2021

SAN CARLOS, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) — Oportun (Nasdaq:OPRT), a mission-driven fintech company, today announced that it will participate in several upcoming investor conferences. Oportun’s Chief Executive Officer, Raul Vazquez, will participate in a moderated fireside chat discussion on November 18, 2021 entitled “Trends in Digital Lending” at the JMP Financial Services and Real Estate Conference. Details for the conference appearances are as follows: JMP Securities Financial Services and Real Estate ConferenceDate: Thursday, November 18, 2021Time: 1:00PM ETWebcast: Trends in Digital Lending Jefferies’ Crossover Consumer Finance SummitDate: Thursday, December 9, 2021Location: Jefferies Financial Group, 520 Madison, New York, NY Links to live webcasts will be accessible in the “Events & Presentations” section...

– Plans to File Comprehensive Form 10-K/A That Includes Restated Results for 2020 and 2019 – – 2020 Restated Net Income Expected to Be In Line With Previously Disclosed Estimates – – 2020 Net Income Lower Than Previously Reported on Form 10-K by $2.3 million – – 2019 Net Income Expected to Be Lower Than Previously Reported on Form 10-K by $2.3 million – – No Expected Impact on Reported Revenue and Cash Flows for 2020 or 2019 – EDGEWOOD, N.Y., Nov. 17, 2021 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero®” or “Company”) (NYSE American: CVU) today provided an update on the restatement of its financial results. On June 7, 2021, the Company announced it needed to restate its full year and quarterly 2020 financial statements due to errors in such financial statements...

Year-to-date revenue of approximately EUR 30.1 million (USD 35.9 million) increased 14.4% year-over-year Q3 revenue of EUR 9.4 million (USD 11.1 million), flat with Q3 2020, reflecting lingering impact of COVID-19 on capital equipment sales Year-to-date US HIFU treatment volumes increased 58% over the comparable period in 2020; strong leading indicator of Focal One adoption by urologists Strong cash position of EUR 45.4 million (USD 52.6 million) Company to host a conference call tomorrow, Thursday, November 18, at 8:30 am ETLYON, France, November 17, 2021 — EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the third quarter of 2021 and provided an update on strategic and operational developments.  Marc Oczachowski, EDAP’s Chairman...

NEWARK, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need, today announced that it has commenced an underwritten public offering of its common stock and pre-funded warrants. All shares of common stock and pre-funded warrants to be sold in the offering will be offered by CymaBay. CymaBay intends to grant the underwriters a 30-day option to purchase up to an aggregate of an additional 15% of the number of shares of its common stock offered in the public offering (including shares underlying the pre-funded warrants). The offering is subject to market and other conditions, and there can be no assurance as to whether...